IL1B and malignant colon neoplasm: The previous study showed that treatment of the HT-29 colon cancer cell line with a combination of TNF-α, INF-γ, and LPS has resulted in the up-regulation of pro-inflammatory enzymes (COX-2 and iNOS) and cytokines (IL-1β and TNF-α) expression [54].